Posts Tagged ‘ICER’

Missing the Human Dimension of Obesity

September 17, 2022 — Yesterday, the Institute for Clinical and Economic Review conducted an impressive public hearing on the effectiveness and value of obesity medicines. ICER deserves credit for developing a complex and remarkably transparent model for objectively evaluating this. However, caution is necessary. This model is sufficiently complex to obscure two important facts about obesity and its treatment. […]

Costly and Effective versus Cheap and Ineffective

September 3, 2022 — ICER – the Institute for Clinical and Economic Review – has released its final report on the effectiveness and value of obesity meds and set a public hearing for September 16. Let’s say it right up front. This private nonprofit is trying to do something that is almost impossibly hard. Making objective sense from the […]

ICER: Seeking Value in Obesity Medicine

July 14, 2022 — We’ve all got our reading assignments. The Institute for Clinical and Economic Review (ICER) has released its draft report on effectiveness and value for the current options in obesity medicine. There’s a lot to process in there. But the bottom line is clear enough. Phentermine/topiramate (Qsymia) offers the best value, says the report. The most […]